$VXRT
Vaxart, Inc.

2020 Q4 Form 10-Q Financial Statement

#000143774920023615 Filed on November 12, 2020

View on sec.gov

Income Statement

Concept 2020 Q4 2020 Q3 2019 Q3
Revenue $356.0K $265.0K $454.0K
YoY Change -90.91% -41.63% 61.57%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $5.130M $4.190M $1.460M
YoY Change 285.71% 186.99% -12.57%
% of Gross Profit
Research & Development $8.590M $4.616M $3.713M
YoY Change 161.09% 24.32% -15.25%
% of Gross Profit
Depreciation & Amortization $860.0K $34.00K $131.0K
YoY Change 14.67% -74.05% 0.77%
% of Gross Profit
Operating Expenses $13.72M $7.854M $5.168M
YoY Change 43.75% 51.97% -16.12%
Operating Profit -$7.589M -$4.714M
YoY Change 60.99% -19.83%
Interest Expense $10.00K $84.00K
YoY Change -66.67% -34.88%
% of Operating Profit
Other Income/Expense, Net -$470.0K -$470.0K -$515.0K
YoY Change -7.84% -8.74% -22.9%
Pretax Income -$13.83M -$8.059M -$5.229M
YoY Change 122.71% 54.12% -20.14%
Income Tax $30.00K $26.00K $31.00K
% Of Pretax Income
Net Earnings -$13.86M -$8.085M -$5.260M
YoY Change 116.27% 53.71% -19.67%
Net Earnings / Revenue -3893.54% -3050.94% -1158.59%
Basic Earnings Per Share
Diluted Earnings Per Share -$126.2K -$75.10K -$323.7K
COMMON SHARES
Basic Shares Outstanding 109.5M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q4 2020 Q3 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $126.9M $133.4M $19.60M
YoY Change 839.78% 580.61% 9.5%
Cash & Equivalents $126.9M $133.4M $19.60M
Short-Term Investments $0.00
Other Short-Term Assets $1.300M $1.700M $1.100M
YoY Change 160.0% 54.55% 10.0%
Inventory
Prepaid Expenses
Receivables $334.0K $250.0K $559.0K
Other Receivables $300.0K $300.0K $0.00
Total Short-Term Assets $128.5M $135.6M $21.25M
YoY Change 630.37% 537.96% 10.7%
LONG-TERM ASSETS
Property, Plant & Equipment $1.480M $662.0K $1.469M
YoY Change 604.76% -54.94% 33.55%
Goodwill $0.00
YoY Change
Intangibles $15.36M $15.79M $17.53M
YoY Change -10.13% -9.88%
Long-Term Investments
YoY Change
Other Assets $372.0K $72.00K $145.0K
YoY Change 163.83% -50.34%
Total Long-Term Assets $24.05M $19.12M $21.44M
YoY Change 23.76% -10.83% 0.19%
TOTAL ASSETS
Total Short-Term Assets $128.5M $135.6M $21.25M
Total Long-Term Assets $24.05M $19.12M $21.44M
Total Assets $152.6M $154.7M $42.70M
YoY Change 312.03% 262.36% 5.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.133M $1.871M $1.049M
YoY Change 150.35% 78.36% -19.31%
Accrued Expenses $4.799M $3.724M $1.603M
YoY Change 5.13% 132.31% 0.19%
Deferred Revenue $110.0K
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $2.800M $3.000M $2.500M
YoY Change 20.0% 47.06%
Total Short-Term Liabilities $11.76M $10.30M $9.154M
YoY Change 28.22% 12.54% 14.43%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $109.0K $18.00K
YoY Change 505.56% -99.87%
Total Long-Term Liabilities $109.0K $0.00 $18.00K
YoY Change 505.56% -100.0% -99.89%
TOTAL LIABILITIES
Total Short-Term Liabilities $11.76M $10.30M $9.154M
Total Long-Term Liabilities $109.0K $0.00 $18.00K
Total Liabilities $29.18M $23.03M $23.79M
YoY Change 21.17% -3.19% -3.28%
SHAREHOLDERS EQUITY
Retained Earnings -$148.9M -$135.0M -$110.3M
YoY Change 27.62% 22.46%
Common Stock $272.3M $266.7M $129.2M
YoY Change 110.08% 106.49%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $123.4M $131.7M $18.90M
YoY Change
Total Liabilities & Shareholders Equity $152.6M $154.7M $42.70M
YoY Change 312.03% 262.36% 5.16%

Cashflow Statement

Concept 2020 Q4 2020 Q3 2019 Q3
OPERATING ACTIVITIES
Net Income -$13.86M -$8.085M -$5.260M
YoY Change 116.27% 53.71% -19.67%
Depreciation, Depletion And Amortization $860.0K $34.00K $131.0K
YoY Change 14.67% -74.05% 0.77%
Cash From Operating Activities -$10.77M -$9.250M -$4.330M
YoY Change 184.17% 113.63% -19.22%
INVESTING ACTIVITIES
Capital Expenditures -$900.0K -$310.0K -$130.0K
YoY Change 8900.0% 138.46% -23.53%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities -$900.0K -$310.0K -$130.0K
YoY Change 8900.0% 138.46% -23.53%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 5.100M 98.61M 7.760M
YoY Change -328.7% 1170.75% -1751.06%
NET CHANGE
Cash From Operating Activities -10.77M -9.250M -4.330M
Cash From Investing Activities -900.0K -310.0K -130.0K
Cash From Financing Activities 5.100M 98.61M 7.760M
Net Change In Cash -6.570M 89.05M 3.300M
YoY Change 8.96% 2598.48% -155.0%
FREE CASH FLOW
Cash From Operating Activities -$10.77M -$9.250M -$4.330M
Capital Expenditures -$900.0K -$310.0K -$130.0K
Free Cash Flow -$9.870M -$8.940M -$4.200M
YoY Change 161.11% 112.86% -19.08%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Security12b Title
Security12bTitle
Common stock, $0.0001 par value
dei Trading Symbol
TradingSymbol
vxrt
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1871000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
852000
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
250000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3619000
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3724000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4565000
CY2020Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
677000
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0000072444
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
109468945
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Document Period End Date
DocumentPeriodEndDate
2020-09-30
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Registrant Name
EntityRegistrantName
Vaxart, Inc.
dei Entity Shell Company
EntityShellCompany
false
dei Entity Small Business
EntitySmallBusiness
true
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2000
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2020Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
537000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
459000
CY2020Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
266687000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
129608000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
915000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3871000
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
146000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
490000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
2966000
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
2966000
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
560000
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2020Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
433000
CY2019Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
433000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1299000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1887000
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8129823
CY2019Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15030424
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
23158593
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9807084
CY2020Q3 us-gaap Assets
Assets
154710000
CY2019Q4 us-gaap Assets
Assets
37032000
CY2020Q3 us-gaap Assets Current
AssetsCurrent
135591000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
17598000
CY2020Q3 us-gaap Cash
Cash
33436000
CY2019Q4 us-gaap Cash
Cash
13511000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
133438000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13526000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11506000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19558000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
119912000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
8052000
CY2020Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1244974
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
9530832
CY2019Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
45476994
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
109468945
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
48254994
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
109468945
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
48254994
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
11000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
5000
CY2020Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
0
CY2019Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
181000
CY2020Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
0
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
0
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1732000
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
433000
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1732000
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1732000
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1731000
CY2020Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
22180000
CY2019Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
22180000
CY2020Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
15794000
CY2020Q3 us-gaap Depreciation
Depreciation
34000
CY2019Q3 us-gaap Depreciation
Depreciation
131000
us-gaap Depreciation
Depreciation
78000
us-gaap Depreciation
Depreciation
386000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1846000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2854000
us-gaap Dilutive Securities
DilutiveSecurities
0
us-gaap Dilutive Securities
DilutiveSecurities
0
CY2020Q3 us-gaap Dilutive Securities
DilutiveSecurities
0
CY2019Q3 us-gaap Dilutive Securities
DilutiveSecurities
0
us-gaap Dividends Common Stock
DividendsCommonStock
0
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.08
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.32
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.23
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.96
CY2020Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1132000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
903000
CY2020Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
5400000
CY2020Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6386000
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5087000
CY2020Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-11000
CY2019Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
11000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-13000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-32000
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4190000
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1455000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10076000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4856000
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-8059000
CY2020Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
15794000
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
17093000
CY2020Q3 us-gaap Interest Expense
InterestExpense
CY2019Q3 us-gaap Interest Expense
InterestExpense
84000
us-gaap Interest Expense
InterestExpense
us-gaap Interest Expense
InterestExpense
288000
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-5229000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-18154000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-11942000
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
26000
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
31000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
205000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
294000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
810000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
136000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3369000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1237000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-1511000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-449000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1384000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-164000
CY2020Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
5000
CY2019Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
58000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
69000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
97000
us-gaap Interest Paid Net
InterestPaidNet
us-gaap Interest Paid Net
InterestPaidNet
195000
CY2020Q3 us-gaap Lease Cost
LeaseCost
214000
CY2019Q3 us-gaap Lease Cost
LeaseCost
253000
us-gaap Lease Cost
LeaseCost
536000
us-gaap Lease Cost
LeaseCost
684000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3150000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1719000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
360000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
348000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
336000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
265000
CY2020Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
419000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
37032000
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
10302000
CY2020Q3 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2020Q3 us-gaap Liabilities
Liabilities
23032000
CY2019Q4 us-gaap Liabilities
Liabilities
24080000
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
154710000
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
7854000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1783000
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
72000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
9174000
CY2020Q3 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
100002000
CY2019Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
15000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
133214000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
18188000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-318000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-838000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12984000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9298000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-8085000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-5260000
us-gaap Net Income Loss
NetIncomeLoss
-18359000
us-gaap Net Income Loss
NetIncomeLoss
-12236000
us-gaap Noncash Or Part Noncash Acquisition Value Of Assets Acquired1
NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
213000
us-gaap Noncash Or Part Noncash Acquisition Value Of Assets Acquired1
NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
3000
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-470000
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-515000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1345000
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
5168000
us-gaap Operating Expenses
OperatingExpenses
20499000
us-gaap Operating Expenses
OperatingExpenses
16105000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-7589000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-4714000
us-gaap Operating Income Loss
OperatingIncomeLoss
-16809000
us-gaap Operating Income Loss
OperatingIncomeLoss
-10159000
CY2020Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
235000
CY2019Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
258000
us-gaap Operating Lease Cost
OperatingLeaseCost
636000
us-gaap Operating Lease Cost
OperatingLeaseCost
703000
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
2731000
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1699000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
841000
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1032000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1472000
CY2020Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
243000
CY2019Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
253000
us-gaap Operating Lease Payments
OperatingLeasePayments
717000
us-gaap Operating Lease Payments
OperatingLeasePayments
740000
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2591000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1990000
CY2020Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.1034
CY2020Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y211D
CY2020Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
529000
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
254000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
141000
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
18000
us-gaap Other Noncash Expense
OtherNoncashExpense
us-gaap Other Noncash Expense
OtherNoncashExpense
93000
us-gaap Payments For Restructuring
PaymentsForRestructuring
2785000
CY2020Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
775000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
321000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
838000
CY2019Q4 us-gaap Restructuring Reserve
RestructuringReserve
3648000
CY2020Q3 us-gaap Restructuring Reserve
RestructuringReserve
14000
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-135020000
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1903000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
453000
CY2020Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
10000000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
3000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
402000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
25951000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
CY2020Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1199000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
669000
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
662000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
210000
us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
1250000
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4616000
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3713000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11272000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11249000
CY2020Q3 us-gaap Restructuring And Related Cost Cost Incurred To Date1
RestructuringAndRelatedCostCostIncurredToDate1
4071000
CY2020Q3 us-gaap Restructuring Charges
RestructuringCharges
-952000
CY2019Q3 us-gaap Restructuring Charges
RestructuringCharges
us-gaap Restructuring Charges
RestructuringCharges
-849000
us-gaap Restructuring Charges
RestructuringCharges
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-116661000
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
265000
CY2019Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
454000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3690000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5946000
CY2020Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
18000
CY2020Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P90D
CY2020Q3 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
1
CY2019Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
211000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1022000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1929000
us-gaap Share Based Compensation
ShareBasedCompensation
3871000
us-gaap Share Based Compensation
ShareBasedCompensation
490000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
6400000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
295180
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1554328
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1600000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
57751
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
85992
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
4957800
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2610000
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
28700000
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6320530
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1811652
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.27
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.74
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
10800000
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2539452
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
2.79
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.32
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
10.57
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.39
CY2020Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.70
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.10
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y65D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P8Y328D
CY2020Q3 us-gaap Short Term Lease Commitment Amount
ShortTermLeaseCommitmentAmount
0
CY2020Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
4000
CY2019Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
4000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
10000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
11000
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
305179
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2020Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
97034000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
97034000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2440000
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
286000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
402000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
131678000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
12952000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
40235000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
15845000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
18903000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
11238000
CY2020Q3 us-gaap Sublease Income
SubleaseIncome
54000
CY2019Q3 us-gaap Sublease Income
SubleaseIncome
53000
us-gaap Sublease Income
SubleaseIncome
163000
us-gaap Sublease Income
SubleaseIncome
162000
CY2020Q3 us-gaap Variable Lease Cost
VariableLeaseCost
29000
CY2019Q3 us-gaap Variable Lease Cost
VariableLeaseCost
44000
us-gaap Variable Lease Cost
VariableLeaseCost
53000
us-gaap Variable Lease Cost
VariableLeaseCost
132000
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
107718578
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
16249032
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
81121045
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
12748665
CY2020Q3 vxrt Accrued Clinical And Manufacturing Expenses Current
AccruedClinicalAndManufacturingExpensesCurrent
1386000
CY2019Q4 vxrt Accrued Clinical And Manufacturing Expenses Current
AccruedClinicalAndManufacturingExpensesCurrent
3228000
vxrt Adjustments To Additional Paid In Capital Disgorgement Of Shortswing Profits Net Of Costs
AdjustmentsToAdditionalPaidInCapitalDisgorgementOfShortswingProfitsNetOfCosts
652000
vxrt Adjustments To Additional Paid In Capital Stock And Warrants Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockAndWarrantsIssuedIssuanceCosts
1278000
CY2018Q1 vxrt Business Combination Stock Conversion Shares Issued Per Common Share Of Surviving Entity
BusinessCombinationStockConversionSharesIssuedPerCommonShareOfSurvivingEntity
0.22148
CY2020Q3 vxrt Contract With Customer Asset Revenue Recognized
ContractWithCustomerAssetRevenueRecognized
214000
CY2019Q4 vxrt Contract With Customer Asset Revenue Recognized
ContractWithCustomerAssetRevenueRecognized
21000
CY2020Q3 vxrt Finitelived Intangible Asset Expected Amortization Year Five And Thereafter
FinitelivedIntangibleAssetExpectedAmortizationYearFiveAndThereafter
8434000
vxrt Impairment Of Property And Equipment
ImpairmentOfPropertyAndEquipment
0
vxrt Impairment Of Property And Equipment
ImpairmentOfPropertyAndEquipment
0
vxrt Issuance Of Warrants To Placement Agents Designees
IssuanceOfWarrantsToPlacementAgentsDesignees
453000
vxrt Issuance Of Warrants To Placement Agents Designees
IssuanceOfWarrantsToPlacementAgentsDesignees
100000
vxrt Issuance Of Warrants To Underwriters Designees
IssuanceOfWarrantsToUnderwritersDesignees
vxrt Issuance Of Warrants To Underwriters Designees
IssuanceOfWarrantsToUnderwritersDesignees
830000
CY2020Q3 vxrt Lessee Finance Lease Number Of Leases
LesseeFinanceLeaseNumberOfLeases
0
CY2020Q3 vxrt Lessee Operating Lease Liability To Be Paid Year Five And Thereafter
LesseeOperatingLeaseLiabilityToBePaidYearFiveAndThereafter
122000
CY2020Q3 vxrt Lessee Operating Lease Number Leases Exceeding One Year
LesseeOperatingLeaseNumberLeasesExceedingOneYear
3
CY2020Q3 vxrt Lessee Operating Lease Number Of Leases
LesseeOperatingLeaseNumberOfLeases
5
CY2020Q3 vxrt Lessee Operating Lease Number Of Right Of Use Leases Terminated
LesseeOperatingLeaseNumberOfRightOfUseLeasesTerminated
1
CY2020Q3 vxrt Lessee Operating Lease Number Of Rightofuse Leases Subleased
LesseeOperatingLeaseNumberOfRightofuseLeasesSubleased
1
CY2020Q3 vxrt Liability Related To Sale Of Future Royalties Current
LiabilityRelatedToSaleOfFutureRoyaltiesCurrent
3008000
CY2019Q4 vxrt Liability Related To Sale Of Future Royalties Current
LiabilityRelatedToSaleOfFutureRoyaltiesCurrent
2916000
CY2020Q3 vxrt Liability Related To Sale Of Future Royalties Noncurrent
LiabilityRelatedToSaleOfFutureRoyaltiesNoncurrent
11698000
CY2019Q4 vxrt Liability Related To Sale Of Future Royalties Noncurrent
LiabilityRelatedToSaleOfFutureRoyaltiesNoncurrent
13416000
CY2020Q3 vxrt Noncash Interest Expense On Liability
NoncashInterestExpenseOnLiability
464000
CY2019Q3 vxrt Noncash Interest Expense On Liability
NoncashInterestExpenseOnLiability
500000
vxrt Noncash Interest Expense On Liability
NoncashInterestExpenseOnLiability
1401000
vxrt Noncash Interest Expense On Liability
NoncashInterestExpenseOnLiability
1560000
vxrt Noncash Revenue Related To Sale Of Future Royalties
NoncashRevenueRelatedToSaleOfFutureRoyalties
3027000
vxrt Noncash Revenue Related To Sale Of Future Royalties
NoncashRevenueRelatedToSaleOfFutureRoyalties
3147000
vxrt Proceeds From Disgorgement Of Shortswing Profits Net Of Costs
ProceedsFromDisgorgementOfShortswingProfitsNetOfCosts
652000
vxrt Proceeds From Disgorgement Of Shortswing Profits Net Of Costs
ProceedsFromDisgorgementOfShortswingProfitsNetOfCosts
vxrt Proceeds From Exercise Of Prefunded Warrants
ProceedsFromExerciseOfPrefundedWarrants
vxrt Proceeds From Exercise Of Prefunded Warrants
ProceedsFromExerciseOfPrefundedWarrants
1083000
CY2020Q1 vxrt Proceeds From Issuance Or Sale Of Equity Net
ProceedsFromIssuanceOrSaleOfEquityNet
9200000
CY2020Q3 vxrt Reserve For Return Of Royalties Current
ReserveForReturnOfRoyaltiesCurrent
CY2019Q4 vxrt Reserve For Return Of Royalties Current
ReserveForReturnOfRoyaltiesCurrent
178000
vxrt Share Based Compensation Arrangement By Share Based Payment Award Canceled
ShareBasedCompensationArrangementByShareBasedPaymentAwardCanceled
9573
vxrt Share Based Compensation Arrangement By Share Based Payment Award Forfeited
ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeited
85910
vxrt Share Based Compensation Arrangement By Share Based Payment Award Shares Available For Grant Decrease From Grants
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantDecreaseFromGrants
-4957800
vxrt Stock And Warrants Issued During Period Value New Issues
StockAndWarrantsIssuedDuringPeriodValueNewIssues
8722000
CY2020Q3 vxrt Stock Issued During Period Value Exercise Of Pre Funded Warrants
StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants
1293000
vxrt Stock Issued During Period Value Exercise Of Pre Funded Warrants
StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants
25951000
CY2019Q3 vxrt Stock Issued During Period Value Exercise Of Pre Funded Warrants
StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants
431000
vxrt Stock Issued During Period Value Exercise Of Pre Funded Warrants
StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants
1083000

Files In Submission

Name View Source Status
0001437749-20-023615-index-headers.html Edgar Link pending
0001437749-20-023615-index.html Edgar Link pending
0001437749-20-023615.txt Edgar Link pending
0001437749-20-023615-xbrl.zip Edgar Link pending
ex_201803.htm Edgar Link pending
ex_201804.htm Edgar Link pending
ex_212784.htm Edgar Link pending
ex_212785.htm Edgar Link pending
ex_212786.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
pipelineqthree.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vxrt-20200930.xml Edgar Link completed
vxrt-20200930.xsd Edgar Link pending
vxrt-20200930_cal.xml Edgar Link unprocessable
vxrt-20200930_def.xml Edgar Link unprocessable
vxrt-20200930_lab.xml Edgar Link unprocessable
vxrt-20200930_pre.xml Edgar Link unprocessable
vxrt20200930_10q.htm Edgar Link pending